Urea cycle defects and acute or chronic liver failure are linked to systemic hyperammonemia and often result in cerebral dysfunction and encephalopathy. Although an important role of the liver in ammonia metabolism is widely accepted, the role of ammonia metabolizing pathways in the liver for maintenance of whole-body ammonia homeostasis in vivo remains ill-defined. Here, we show by generation of liver-specific Gln synthetase (GS)-deficient mice that GS in the liver is critically involved in systemic ammonia homeostasis in vivo. Hepatic deletion of GS triggered systemic hyperammonemia, which was associated with cerebral oxidative stress as indicated by increased levels of oxidized RNA and enhanced protein Tyr nitration. Liver-specific GS-deficient mice showed increased locomotion, impaired fear memory, and a slightly reduced life span. In conclusion, the present observations highlight the importance of hepatic GS for maintenance of ammonia homeostasis and establish the liver-specific GS KO mouse as a model with which to study effects of chronic hyperammonemia.
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hepatic encephalopathy | metabolic zonation | oxidative stress | RNA oxidation | glutamine H epatic ammonia and Gln metabolism are embedded into a structural/functional organization in the liver acinus, which allows efficient ammonia detoxification by the liver (1, 2) . Hepatic urea synthesis in periportal hepatocytes is dependent on the activity of carbamoylphosphate synthetase, the rate-controlling enzyme of the urea cycle requiring ammonia as a substrate (3) . The affinity of carbamoylphosphate synthetase for ammonia is low, and adequate flux through the urea cycle requires the establishment of high ammonia concentrations in periportal hepatocytes, which is achieved through ammonia amplification by periportal glutaminase activity (1-3). Excess ammonia not used by urea synthesis is taken up with high affinity by a small perivenous hepatocyte population (so-called "perivenous scavenger cells") (1), which detoxifies ammonia by amidation of Glu (4) . This reaction is catalyzed by Gln synthetase (GS), which is specifically expressed in this small population of hepatocytes surrounding the terminal hepatic venule but not in other hepatocytes (4) (5) (6) . This high-affinity ammonia removal by perivenous hepatocytes thus prevents spillover of hepatic ammonia into the systemic circulation. The acinar compartmentation of urea synthesis, Gln hydrolysis, and Gln synthesis therefore allows the generation of sizable ammonia concentrations in hepatic tissue needed for urea formation without the risk of toxic ammonia concentrations in systemic circulation (1) .
Ammonia is toxic, particularly to the brain, where it can trigger hepatic encephalopathy (HE). HE is seen as the clinical manifestation of a low-grade cerebral edema with oxidative/nitrosative stress and subsequent derangements of signal transduction, neurotransmission, synaptic plasticity, and oscillatory networks in the brain (7) (8) (9) . In particular, the oxidative/nitrosative stress response results in protein Tyr nitration (PTN) and RNA oxidation (9, 10).
Astrocytes in close proximity to the blood-brain barrier exhibit strong PTN, possibly affecting its permeability (11) . Data derived from HE animal models suggest a relationship between impaired functions of brain regions involved in cognition, learning, memory formation, and motor control, as well as elevated markers for oxidative stress in the hippocampus (12, 13) , cerebral cortex (14) , and cerebellum (15, 16) . Consistently, increased markers for oxidative stress, such as PTN and RNA oxidation, have also been shown in postmortem human brain tissue of patients with liver cirrhosis and HE (17) . In mice, ammonia can also inhibit potassium buffering by astrocytes, which results in increased extracellular potassium and may contribute to neuronal depolarization and dysfunction, and, consequently, altered behavior (18) .
Liver damage can trigger defects in the ammonia metabolizing pathways, which consequently increase ammonia levels in circulating blood (19, 20) . For example, LPS-induced liver injury results in PTN of hepatic GS, which inactivates the enzyme (21) . The impact of the urea cycle for ammonia metabolism can be seen in children with urea cycle defects, who exhibit hyperammonemia and cognitive symptoms (22) . In turn, hereditary GS deficiency in humans is a rare disorder leading to Gln deficiency and severe disease with a lethal outcome (23) . Although destruction of perivenous hepatocytes by carbon tetrachloride intoxication impairs ammonia detoxification in perfused rat liver (24) , the in vivo significance of the GS in perivenous hepatocytes has remained elusive. Because Gln can be synthesized in a wide variety of tissues Significance Ammonia metabolism in the liver is critical to prevent serious clinical conditions, such as hepatic encephalopathy. It was hypothesized that the Gln synthetase (GS) can metabolize ammonia with high affinity in the perivenous region of the liver. However, the in vivo relevance of this metabolic pathway remains unclear in view of other intra-and extrahepatic ammonia metabolizing pathways. Here, we show by creating a conditional GS KO mouse that specific deletion of the GS in the liver results in increased ammonia levels in the blood, induction of oxidative stress in brain tissue, and behavior abnormalities. In conclusion, GS in the liver is a key player in the maintenance of ammonia homeostasis.
(4), specific deletion of hepatic GS would not be expected to result in Gln deficiency. However, lack of hepatic GS may disrupt perivenous ammonia metabolism, thus leading to increased ammonia concentrations in systemic blood.
To test this hypothesis, gene-targeted mice lacking functional hepatic GS were generated and analyzed. As a result of liverspecific GS deletion, mice developed systemic hyperammonemia, which was accompanied by cerebral RNA oxidation, PTN, motoric and behavioral abnormalities, and a reduced life span.
Results
Effect of Liver-Specific GS Deletion on Liver Tissue Integrity, Zonation, and Systemic Ammonia Levels. Liver injury can result in a reduction of hepatic GS activity (21, 24) . Because other potent ammonia detoxicating mechanisms exist in the body, the role of the GS in perivenous liver cells remains controversial. To investigate the role of GS, we created conditional GS KO mice (Fig. 1A) , which were crossed with a mouse strain where Cre is expressed under the albumin promotor (25) . As expected, GS was strongly expressed in liver tissue in locus of X-over P1 (loxP) sites flanked by glutamateammonia ligase gene (Glul fl/fl ) mice in the absence of Cre recombinase but was undetectable in Glul fl/fl × albumin promotercontrolled Cre recombinase gene (Alb-Cre + ) mice ( Fig. 1 B and  C) . Deletion of GS in the liver did not affect GS expression in the brain or in muscle tissue ( Fig. 1 D and E) . GS activity was high in liver tissue from Glul fl/fl mice, whereas only residual GS activity was detected in liver tissue from Glul fl/fl × Alb-Cre + mice (Fig. 1F) , which is probably attributable to tissue resident macrophages (26) . Next, we investigated whether hepatic deletion of GS affected liver architecture or damage. Histologically, no difference between WT and Glul fl/fl × Alb-Cre + mice in snap-frozen liver sections was observed ( Fig. 2A) . Furthermore, activities of Asp and Ala aminotransferases in serum were not different between WT and KO mice, indicating that the absence of hepatic GS did not result in liver damage (Fig. 2B) . Although GS was selectively deleted in perivenous hepatocytes (Fig. 2C) , ornithine aminotransferase (OAT), as well as Rhesus family B glycoprotein, which show similar acinar localization as GS, were still detectable in these specialized cells (27, 28) (Fig. 2 C and D) . These data indicated that the zonal organization of the liver was not affected by the liver-specific GS KO. However, when we checked blood ammonia levels, strongly elevated ammonia concentrations were observed in blood plasma from KO mice compared with WT mice (Fig. 2E ). This increase in plasma ammonia concentration was probably not due to a urea cycle defect, because expression of genes encoding for enzymes of the urea cycle in the liver was similar in WT and Glul fl/fl × Alb-Cre + mice (Fig. S1A ). Moreover, serum urea nitrogen concentrations did not differ between WT and Glul fl/fl × AlbCre + mice (Fig. S1B) . Furthermore, serum Gln, Glu, and Ala concentrations were not significantly different between Glul fl/fl and Glul fl/fl × Alb-Cre + mice (Fig. S1C) . Taken together, these data indicate that liver-specific deletion of GS does not affect liver architecture but allows ammonia spillover into the systemic circulation, thereby leading to hyperammonemia.
Liver-Specific GS KO Triggers PTN and RNA Oxidation in Mouse Brain.
Ammonia intoxication and HE were shown to trigger PTN nitration and RNA oxidation in the rat and human brain, respectively (10, 17, 21, 29) . Therefore, we analyzed whether these effects could also be observed in brain tissue from liver-specific GS KO mice. Whereas PTN was enhanced in the cerebellum, hippocampus, and somatosensory cortex of Glul fl/fl × Alb-Cre + mice (Fig. 3 A-C) , it was similar to PTN in WT mice in the piriform cortex (Fig. 3D) .
Thus, nitration of proteins due to chronic ammonia intoxication affects specific regions of the brain (Fig. 3E) . Next, we investigated whether RNA oxidation was present in brain tissue using immunofluorescence. As evidenced by anti-8-hydroxy-2-(de)oxyguanosine [8-OH(d)G] immunoreactivity, RNA oxidation was consistently found in the cerebellum, hippocampus, and somatosensory cortex (Fig. 4 A-C) but not in the piriform cortex (Fig.  4D ). When brain slices were treated with RNase, no anti-8-OH(d)G immunoreactivity was detectable on the brain slices, indicating that the oxidation was specific for RNA (Fig. S2) . These results were also confirmed with Northwestern blotting (Fig. 4E and Fig.  S3 A-D) . Interestingly, in the cerebellum of mice lacking hepatic GS, we identified exceptionally high levels of oxidized RNA in Purkinje cells (Fig. S4) , which critically control motor functions (30) . Taken together, specific deletion of GS in the liver results in increased ammonia levels and, consequently, biochemical changes in brain tissue of Glul fl/fl × Alb-Cre + mice. (Fig. 5A ). In line with this finding, cerebrocortical Iba1 and CD14 mRNA (Fig.  5B) and protein (Fig. S5A ) levels were unchanged in Glul fl/fl × AlbCre + mice compared with Glul fl/fl mice. In the brain, proinflammatory cytokines are largely synthesized by activated microglia (33) . Also, mRNA (Fig. 5C) and protein (Fig. S5B ) levels of the proinflammatory cytokines IL-1β, IL-6, and TNF-α remained unchanged in the cerebral cortex of Glul fl/fl × Alb-Cre + mice compared with Glul fl/fl mice. These data suggest that systemic hyperammonemia in Glul fl/fl × Alb-Cre + mice is not associated with microglia activation and increased synthesis of proinflammatory cytokines in cerebral cortex.
Glul
fl/fl × Alb-Cre + Mice Exhibit Behavioral Abnormalities. Changes in ammonia levels in patients can trigger signs of HE. We therefore tested whether liver-specific deletion of GS resulted in behavioral abnormalities. Interestingly, when we monitored animal activity using light barrier-equipped cages, increased activity of Glul fl/fl × Alb-Cre + mice compared with WT mice was observed (Fig. 6A) . Consistently, the overall distance traveled by Glul fl/fl × Alb-Cre + mice was increased compared with Glul fl/fl mice (Fig.  6B) . Furthermore, using the O-Maze test, Glul fl/fl × Alb-Cre + mice spent more time in the open arms compared with control animals (Fig. 6C) . In turn, Glul fl/fl × Alb-Cre + mice spent less time in the protected arms than Glul fl/fl mice (Fig. 6D) . Taken together, these data indicate that chronic hyperammonemia results in behavioral abnormalities. Furthermore, when we monitored the WT and Glul fl/fl × Alb-Cre + mice over time, we observed slightly reduced survival of GS-deficient mice compared with WT controls (Fig. S6) , indicating that chronic ammonia exposure may reduce the life span in vivo. Taken together, these data indicate that deletion of GS in the liver results in hyperammonemia, phenotypic changes in brain tissue, and behavioral abnormalities.
Discussion
According to the present observations, lack of hepatic GS is followed by a marked increase of plasma ammonia levels. Hepatic GS is selectively expressed in a small population of perivenous hepatocytes (4-6, 34, 35) . This expression pattern depends on Wnt-mediated activation of the transcriptional coactivator β-catenin (36, 37) , which is also involved in hepatocyte proliferation (38) (39) (40) . Consequently, liver-specific β-catenin-deficient mice exhibit defective GS activity in the liver (36) . In our study, the severe hyperammonemia of the Glul fl/fl × Alb-Cre + mice highlights the importance of this enzyme in a small population of perivenous hepatocytes (so-called "perivenous scavenger cells") as a high-affinity ammonia scavenger, which prevents ammonia spillover from the periportal urea-synthesizing compartment into the systemic circulation. The present observations show the in vivo relevance of a hypothesis postulated almost three decades ago (1, 2, 24) . As illustrated in Figs. 1C and 2C , the enzyme is specifically expressed in a small subpopulation of perivenous hepatocytes and is completely absent in the remainder of liver parenchyma. Thus, expression of the enzyme in this small population of hepatocytes, which amounts to only 6-7% of all liver parenchymal cells (5), is pivotal for the maintenance of nontoxic ammonia levels in the organism. The hyperammonemia in hepatic failure is thus not simply the result of impaired urea formation but may, in large part, result from an impaired ability of the perivenous cells to incorporate ammonia into Gln. Apart from perivenous hepatocytes, several other cell types, including skeletal muscle, can take up ammonia, and thus contribute to ammonia detoxification (41) . However, extrahepatic GS, which is intact in Glul fl/fl × Alb-Cre + mice, is apparently not sufficient to prevent hyperammonemia in arterial blood and to compensate for the lack of GS in the liver. The safeguard of perivenous ammonia detoxification allows the periportal hepatocytes to generate ammonia by Gln hydrolysis as a substrate for periportal urea synthesis, which is a low-affinity system for ammonia detoxification (1). The ammonia generated by hepatic glutaminase, which is expressed in periportal hepatocytes, adds to the ammonia generated in the gastrointestinal tract. Such high ammonia concentrations are apparently tolerated by hepatocytes but are toxic to the brain (42) . Arterial ammonia readily crosses the blood-brain barrier, thus entering cerebral tissue (43) . In the brain, ammonia leads to Gln formation, astrocyte swelling, and generation of reactive oxygen and nitrogen species. Astrocyte swelling and oxidative/nitrosative stress affect signal transduction, neurotransmission, synaptic plasticity, and oscillatory networks in the brain (42) . The present observations revealed enhanced PTN and RNA oxidation in brain regions of Glul fl/fl × Alb-Cre + mice, whose function is compromised in HE. Functions affected in HE include memory formation in the hippocampus (44); processing of sensory stimuli, such as perception, in the somatosensory cortex (45) ; and motor functions in the cerebellum (46) . Interestingly, in the cerebellum of mice lacking hepatic GS, we identified exceptionally high levels of oxidized RNA in Purkinje cells, which critically control motor functions (30) . In line with deranged cerebral motor control, the present study identified increased locomotion in mice lacking hepatic GS with liver damage and/or cholestasis due to bile duct ligation (47, 48) , portocaval shunting (49), or portal vein ligation (14) . This difference may suggest a role of impaired liver metabolism other than ammonia detoxification for decreased locomotion in these HE animal models. One may also speculate that A B C D mRNA expression levels of Iba1, CD14, IL-1β, IL-6, or TNF-α were normalized to succinate dehydrogenase complex subunit A (SDHA) mRNA levels.
chronic hyperammonemia from birth in Glul fl/fl × Alb-Cre + mice may trigger so far unknown adaptations that are not present in other experimental settings or in patients with liver failure. However, that chronic hyperammonemia in Glul fl/fl × Alb-Cre + mice does not promote anxious behavior is consistent with findings obtained from bile duct-ligated rats (47) or rats after portocaval anastomosis (50) . Interestingly, oxidative stress markers were not elevated in the piriform cortex of liver-specific GS KO mice. Presently, the underlying reason, as well as the functional significance of this finding, remains enigmatic and needs to be explored in further studies. Our findings also demonstrate that chronic hyperammonemia in this mouse model is not sufficient to activate microglia in the cerebral cortex, which contrasts with findings on mouse brain after acute liver failure due to liver ischemia or intoxication (51) or findings on human brain tissue from cirrhotic patients with HE (32, 52) . These discrepancies may be explained by species differences, allowance for compensatory mechanisms in chronic hyperammonemia, and/or the complexity or severity of the pathophysiological setting in humans with liver cirrhosis. Therefore, other factors, such as systemic inflammation in acute liver failure (51) and HE (53) , might contribute to cerebral microglia activation in HE (32, 52) . Indeed, a recent transcriptome analysis on postmortem human brain samples indicated that systemic inflammation may trigger altered cerebral expression of genes involved in inflammation in patients with liver cirrhosis and HE (52) . Furthermore, our results demonstrate that cerebral synthesis of proinflammatory cytokines as observed in some animal models for HE is not solely explained by hyperammonemia (16, 31) , in line with previous data (13, 14) . Consistent with the present findings, data derived from postmortem human brain samples consistently show no up-regulation of proinflammatory cytokine mRNA or protein in the brain tissue of patients with liver cirrhosis and HE (32, 52, 54) .
As shown in this paper, expression of functional GS in the perivenous hepatic scavenger cell population is critical for ammonia homeostasis in vivo. Liver cirrhosis in animal models and man and hepatocellular carcinoma are associated with strongly reduced GS activity, followed by hyperammonemia (2, (55) (56) (57) . In cirrhosis with collaterals, down-regulation of GS in scavenger cells may be related to portocaval shunting (3, 58, 59 ). Here, it should be noted that glutaminase activity in the cirrhotic liver increases four-to fivefold to compensate for a marked reduction of the capacity for urea synthesis, thereby maintaining a life-compatible urea cycle flux (55) . Clinical conditions such as sepsis (21) or portocaval anastomosis (58) are associated with reduced GS activity as a consequence of a scavenger cell defect, although flux through periportal urea synthesis is not affected.
The crucial role of hepatic GS for the maintenance of ammonia homeostasis as shown in the present study is also supported by a recent study using muscle-specific GS KO mice, where arterial ammonia levels were only marginally elevated compared with Glul fl/fl mice (60). Here, it was concluded that skeletal muscle may only contribute about 3% of daily whole-body ammonia detoxification. Moreover, our study shows no compensatory up-regulation of GS in skeletal muscle in Glul fl/fl × Alb-Cre + mice. Notably, the chronic hyperammonemia from birth in the absence of liver damage in Glul fl/fl × Alb-Cre + mice may resemble hyperammonemia in children with inborn urea cycle disorders, who also exhibit cognitive and motor deficits (22) . These disorders emphasize the importance of the urea cycle for ammonia clearance. Accordingly, both the high-affinity and low-affinity systems represent two independent primary systems in the liver for ammonia removal.
In conclusion, the present study shows that lack of GS activity in a small subpopulation of perivenous hepatocytes leads to hyperammonemia and cerebral ammonia intoxication.
Materials and Methods
Animals. Gene-targeted mice lacking functional hepatic GS were generated by inserting a loxP site, together with a flip-recombinase target flanked neomycin resistance cassette, downstream of the 3′ end of exon 3 and a single loxP site between exon 1a and exon 1b (GenOway; Fig. 1A ). Resulting mice were crossed with deleter mice expressing the flippase recombinase to remove the resistance cassette. Glul fl/fl mice were backcrossed to C57BL/6J background more than 10 times. Next, mice were crossed to a mouse expressing the Cre recombinase under the albumin promotor (25) , resulting in liver-specific deletion of GS. Animals appeared viable and fertile, and showed no signs of distress. Animals were kept under specific pathogen-free conditions. Age-and sex-matched animals weighing over 20 g were used for experiments. Most experiments were carried out with littermate controls of mice aged between 8 and 12 wk. For determination of locomotor activity, animals between 3 and 75 wk of age were transferred into a light barrierequipped cage monitored by a computer system (ActiMot/MoTil; TSESystems). Animals were allowed to adapt to the new environment for 24 h prior to starting the measurement for another 24 h. All animal experiments were reviewed and approved by the appropriate authorities, and were performed in accordance with the German animal protection law (Landesamt für Natur, Umwelt und Verbraucherschutz Recklinghausen, Regierungspräsidium Tübingen, Tierveruchsanlage Düsseldorf). Genotyping and the O-Maze test of mice were performed as described in SI Materials and Methods.
Tissue Sampling. Detailed information on tissue sampling is provided in SI Materials and Methods. The cerebral cortex was further dissected due to visible morphological characteristics (61) .
Video-Tracking. For data acquisition, animals were video-tracked by a 302050-SW-KIT-2-CAM camera (TSE-Systems) at a resolution of 0.62-0.72 pixel and analyzed using the tracking software VideoMot2 (TSE-Systems).
Western Blot Analysis. Western blot analysis was carried out as described in SI Materials and Methods and previously (11) .
Northwestern Blot Analysis. Northwestern blot analysis was carried out as described in SI Materials and Methods and previously (10) .
Immunofluorescence Analysis. Immunofluorescence analysis was carried out as described in SI Materials and Methods and previously (10) .
GS Activity Assay. GS activity was measured according to the γ-glutamyl transferase reaction as described recently (21) and in SI Materials and Methods.
Real-Time PCR. Quantitative real-time PCR is described in detail in SI Materials and Methods, including PCR primer sequences.
Serum Liver Enzyme Activity. Activity of Ala aminotransferase and Asp aminotransferase was measured in serum using a serum multiple biochemical analyzer (Ektachem DTSCII; Johnson & Johnson).
Quantification of Urea Nitrogen in Serum and Urine. Urea nitrogen was quantified using a Spotchem analyzer (Axonlab). Serum samples were prediluted 1:5 and urine samples were prediluted 1:50 in PBS (Panbiotech).
Blood Ammonia Determination. Blood ammonia was measured within 3 min after blood sampling from the right heart ventricle using an Ammonia Checker II (Daiichi Kagaku Co. Ltd., distributed by Nobis Labordiagnostica GmbH).
Statistical Analysis. Data are provided as means ± SEM, and n represents the number of animals tested. All data were tested for significance using a paired or unpaired Student's t test or one-way ANOVA. Only results with P < 0.05 were considered statistically significant.
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